427 related articles for article (PubMed ID: 12464647)
21. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
Daibata M; Speck SH; Mulder C; Sairenji T
Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
[TBL] [Abstract][Full Text] [Related]
22. Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients.
Sacaze C; Henry S; Icart J; Mariamé B
Virus Res; 2001 Dec; 81(1-2):133-42. PubMed ID: 11682132
[TBL] [Abstract][Full Text] [Related]
23. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
[TBL] [Abstract][Full Text] [Related]
24. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders.
Schuster V; Ott G; Seidenspinner S; Kreth HW
Blood; 1996 Feb; 87(4):1579-85. PubMed ID: 8608250
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
[TBL] [Abstract][Full Text] [Related]
26. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
[TBL] [Abstract][Full Text] [Related]
27. BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines.
Needham J; Adamson AL
Virus Genes; 2019 Dec; 55(6):779-785. PubMed ID: 31552622
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
29. Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Okuno Y; Murata T; Sato Y; Muramatsu H; Ito Y; Watanabe T; Okuno T; Murakami N; Yoshida K; Sawada A; Inoue M; Kawa K; Seto M; Ohshima K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Narita Y; Yoshida M; Goshima F; Kawada JI; Nishida T; Kiyoi H; Kato S; Nakamura S; Morishima S; Yoshikawa T; Fujiwara S; Shimizu N; Isobe Y; Noguchi M; Kikuta A; Iwatsuki K; Takahashi Y; Kojima S; Ogawa S; Kimura H
Nat Microbiol; 2019 Mar; 4(3):404-413. PubMed ID: 30664667
[TBL] [Abstract][Full Text] [Related]
30. Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein.
Adamson AL; Wright N; LaJeunesse DR
Genetics; 2005 Nov; 171(3):1125-35. PubMed ID: 16079238
[TBL] [Abstract][Full Text] [Related]
31. Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.
Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV
J Clin Microbiol; 2012 Mar; 50(3):609-18. PubMed ID: 22205789
[TBL] [Abstract][Full Text] [Related]
32. Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa.
Grunewald V; Bonnet M; Boutin S; Yip T; Louzir H; Levrero M; Seigneurin JM; Raphael M; Touitou R; Martel-Renoir D; Cochet C; Durandy A; Andre P; Lau W; Zeng Y; Joab I
Int J Cancer; 1998 Feb; 75(4):497-503. PubMed ID: 9466647
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus: the first human tumor virus and its role in cancer.
Pagano JS
Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
[TBL] [Abstract][Full Text] [Related]
34. Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases.
Hayes DP; Brink AA; Vervoort MB; Middeldorp JM; Meijer CJ; van den Brule AJ
Mol Pathol; 1999 Apr; 52(2):97-103. PubMed ID: 10474689
[TBL] [Abstract][Full Text] [Related]
35. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
36. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China.
Ji KM; Li CL; Meng G; Han AD; Wu XL
Arch Virol; 2008; 153(10):1949-53. PubMed ID: 18807115
[TBL] [Abstract][Full Text] [Related]
37. Thymic carcinoma with a defective Epstein-Barr virus encoding the BZLF1 trans-activator.
Patton DF; Ribeiro RC; Jenkins JJ; Sixbey JW
J Infect Dis; 1994 Jul; 170(1):7-12. PubMed ID: 8014523
[TBL] [Abstract][Full Text] [Related]
38. Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells.
Delecluse S; Poirey R; Zeier M; Schnitzler P; Behrends U; Tsai MH; Delecluse HJ
J Virol; 2020 May; 94(10):. PubMed ID: 32102884
[TBL] [Abstract][Full Text] [Related]
39. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.
Huang J; Chen H; Hutt-Fletcher L; Ambinder RF; Hayward SD
J Virol; 2003 Dec; 77(24):13267-74. PubMed ID: 14645583
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus BZLF1 gene polymorphisms: malignancy related or geographically distributed variants?
Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV
Clin Microbiol Infect; 2014 Nov; 20(11):O861-9. PubMed ID: 24666405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
